Rat liver tissue mitochondrial membrane chromatographic column as well as preparation method and application thereof

A rat liver tissue mitochondrial membrane chromatography column was prepared by combining differential centrifugation and ultrasonic disruption with silica gel physical adsorption. This method solves the problem of complex and time-consuming preparation processes in existing technologies, and enables rapid and effective preparation and application of mitochondrial membrane chromatography columns.

CN119000901APending Publication Date: 2024-11-22XI AN JIAOTONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310574339.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-22
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing mitochondrial membrane chromatography preparation processes are complex, time-consuming, consume large amounts of reagents, and have demanding equipment requirements. Furthermore, the preparation process may damage the mitochondrial membrane, and characterization data is lacking, making it difficult to guarantee the reliability of the method.

Method used

Mitochondria were extracted from rat liver tissue by differential centrifugation, the mitochondrial membrane was disrupted by sonication, and a mitochondrial membrane stationary phase was prepared by co-incubation with spherical silica gel using the physical adsorption of silica gel. Finally, a mitochondrial membrane chromatographic column was obtained by wet packing.

Benefits of technology

A rapid and efficient method for preparing mitochondrial membrane chromatography columns has been achieved, reducing damage to the mitochondrial membrane. The prepared columns exhibit good specificity, selectivity, and repeatability, and extend column life.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119000901A_ABST
    Figure CN119000901A_ABST
Patent Text Reader

Abstract

The invention discloses a mitochondrial membrane chromatographic column of rat liver tissue as well as a preparation method and application of the mitochondrial membrane chromatographic column. The method comprises the following steps: firstly, separating mitochondria from a rat liver tissue by using a differential centrifugation method, and ultrasonically crushing the mitochondria into a mitochondria membrane; then co-incubating the mitochondrial membrane and macroporous silica gel, and adsorbing the mitochondrial membrane on the surface of the silica gel under the physical adsorption action of the silica gel to obtain a mitochondrial membrane stationary phase; and finally, carrying out wet packing on the stationary phase to obtain the mitochondrial membrane chromatographic column. Through investigation, the chromatographic column has good applicability, can screen mitochondrial effector molecules and research the interaction between the mitochondrial effector molecules and mitochondria, and can be used as a new tool for researching mitochondrial biomedicine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a rat liver tissue mitochondrial membrane chromatography column and a preparation method and application thereof. Background Art

[0002] Mitochondria are important organelles in cells and the main site of metabolism in the body. Their dysfunction is associated with a variety of diseases, including neurodegenerative diseases. Mitochondrial effector molecules refer to a class of molecules that can directly or indirectly regulate mitochondrial function, mainly including mitochondrial nutrients, mitochondrial targeted drugs, and other molecules that inhibit or activate mitochondrial function. Traditional mitochondrial effector molecule screening methods rely on pharmacological verification of purified molecules, which is costly and has low throughput. Therefore, it is of great significance to establish a method that can quickly screen mitochondrial effector molecules and study their interactions with mitochondria.

[0003] Cell membrane chromatography is a high-throughput screening method that can screen active ingredients targeting specific receptors from complex systems. This technology uses the cell lipid bilayer membrane containing receptors as the separation medium, has the dual characteristics of biological activity recognition and chromatographic separation, and has been widely used in drug screening and other fields. Similar to the cell membrane, mitochondria have a double membrane structure, and its inner and outer membranes contain a large number of receptor proteins, which can be used as potential targets for targeting mitochondrial effectors and for the screening of mitochondrial effectors, namely mitochondrial membrane chromatography technology. The current research in this area is as follows: Wainer's research group used a solubilization buffer to dissolve the extracted mitochondria into membrane fragments. The solubilization process was carried out under low temperature and oscillation conditions for 18 hours, and then the dissolved membrane fragments were incubated with artificial membrane particles (silica particles with phosphatidylcholine bonded to the surface) for 1 hour, and finally the solubilization buffer was removed using a dialysis column. The dialysis process took 24 hours, and finally the stationary phase was prepared.

[0004] The mitochondrial membrane chromatography technology proposed in existing reports has the following problems: the preparation process is complicated, the reagent consumption is large, the preparation time is long, the required equipment is large and the conditions are harsh, which makes the experimental process difficult to repeat; the solubilization process in the preparation may also have a certain destructive effect on the original environment of the mitochondrial membrane receptors, causing the loss of mitochondrial membrane proteins; the preparation process lacks characterization data, making it difficult to ensure the reliability of this method; and only the frontier analysis test of its chromatographic column on positive drugs is reported, while the key parameters of the chromatographic column applicability: specificity, selectivity, repeatability and column life are not reported.

[0005] Therefore, there is currently a lack of a new preparation route for the preparation of mitochondrial membrane chromatography. Summary of the invention

[0006] The technical problem to be solved by the present invention is to provide a rat liver tissue mitochondrial membrane chromatography column and its preparation method and application in view of the deficiencies of the above-mentioned prior art. The method uses ultrasound and grinding methods to treat broken mitochondria, and then uses the physical adsorption of ordinary silica gel to adsorb the mitochondrial membrane. The preparation process is fast and efficient, the operation is simple and easy to implement, and the damage to the mitochondrial membrane is minimized. The specificity, selectivity, repeatability and column life of the prepared chromatographic column are all good.

[0007] In order to achieve the above object, the present invention adopts the following technical solutions:

[0008] The first aspect of the present invention provides a method for preparing a rat liver tissue mitochondrial membrane chromatography column, which comprises the following steps: extracting rat liver tissue by differential centrifugation to obtain mitochondria; ultrasonically crushing the mitochondria in an ice bath to break the membrane to obtain a mitochondrial membrane fragment homogenate; mixing the mitochondrial membrane fragment homogenate with silica gel in a reaction container, incubating and centrifuging to obtain a mitochondrial membrane stationary phase; treating the mitochondrial membrane by wet column packing to obtain the rat liver tissue mitochondrial membrane chromatography column.

[0009] Furthermore, the ultrasonic crushing and membrane rupture specifically includes the following parameters: power 130W, frequency 20kHz, amplitude 40%, 2s / time, interval 20s, 5 cycles.

[0010] Furthermore, the silica gel is spherical granular silica gel, the diameter of a single silica gel particle is 5 μm, and the diameter of the pore size is 10 nm.

[0011] Furthermore, the incubation time is 12 hours; the specific parameters of the centrifugation are: 12000g, centrifugation for 20 minutes.

[0012] Furthermore, the method also includes: using positive drugs and negative drugs to examine the specificity, selectivity, repeatability and column life applicability parameters of the rat liver tissue mitochondrial membrane chromatography column respectively.

[0013] The second aspect of the present invention provides a rat liver tissue mitochondrial membrane chromatography column prepared by the above-mentioned method for preparing a rat liver tissue mitochondrial membrane chromatography column.

[0014] The third aspect of the present invention provides the use of the rat liver tissue mitochondrial membrane chromatography column as described above in the field of screening mitochondrial effector molecules and studying the interaction between mitochondrial membrane and effector molecules.

[0015] Compared with the prior art, the present invention has the following innovations and advantages:

[0016] The present invention discloses a mitochondrial membrane chromatography column of rat liver tissue and a preparation method and application thereof. The method first uses differential centrifugation to separate mitochondria from rat liver tissue, and then ultrasonically breaks the mitochondria into mitochondrial membranes; then the mitochondrial membranes are co-incubated with macroporous silica gel, and the physical adsorption of silica gel can adsorb the mitochondrial membranes on the surface of silica gel to obtain a mitochondrial membrane stationary phase; finally, the stationary phase is wet-packed to obtain a mitochondrial membrane chromatography column.

[0017] 1) In the process of extracting mitochondrial membrane, the reported solubilization method takes 18 hours, which is time-consuming and has a large degree of damage to the mitochondrial membrane. The present invention adopts the method of ultrasonic disruption, which is simple to operate and easy to implement, takes only less than 10 minutes, improves the preparation efficiency, slows down the degradation of mitochondrial membrane protein over time, and minimizes the damage to the mitochondrial membrane.

[0018] 2) When preparing the mitochondrial membrane stationary phase, the reported preparation method is to incubate the dissolved mitochondrial membrane solution with the immobilized artificial membrane particles (silica gel particles with phosphatidylcholine bonded on the surface, which can enhance the adsorption effect on the phospholipid membrane) for 1 hour, and then dialyze to remove the solubilization buffer. The dialysis step takes 24 hours. This method is time-consuming and costly. The present invention co-incubates the broken mitochondrial membrane fragments with the silica gel under vacuum shock overnight, which is low-cost and time-consuming.

[0019] 3) In the process of investigating the suitability of the chromatographic column, some reports have only measured the performance of positive drugs on the chromatographic column. The present invention has conducted a comprehensive investigation on the key parameters of the chromatographic column, such as specificity, selectivity, repeatability and column life, and the results are all good. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] One or more embodiments are exemplarily described by pictures in the corresponding drawings, and these exemplifications do not constitute limitations on the embodiments. Unless otherwise stated, the pictures in the drawings do not constitute proportional limitations.

[0021] Figure 1 It is a flow chart of a method for preparing a rat liver tissue mitochondrial membrane chromatography column provided by an embodiment of the present invention;

[0022] Figure 2 The expression of mitochondria and mitochondrial membrane-related proteins in tissue homogenate detected by Western blot in the embodiment of the present invention (Mean±SEM, n=3);

[0023] Figure 3 is a transmission electron microscope observation image of mitochondria and mitochondrial membrane in an embodiment of the present invention;

[0024] Figure 4 is a scanning electron microscope image of silica gel and MMSP in an embodiment of the present invention;

[0025] Figure 5 is an X-ray photoelectron spectroscopy (XPS) result diagram in an embodiment of the present invention;

[0026] Figure 6 is an immunofluorescence image of MMSP in an embodiment of the present invention;

[0027] Figure 7 It is the chromatogram of the positive drug in the embodiment of the present invention on the silica gel column, Hela / CMC column and MMC column;

[0028] Figure 8 is a chromatogram of the positive drug, the negative drug and the drug solvent on the MMC column in the embodiment of the present invention;

[0029] Fig. 9 This is a graph investigating the life of an MMC column in an embodiment of the present invention (Mean±SEM, n=3). DETAILED DESCRIPTION

[0030] In order to make the process of preparing mitochondrial membrane chromatography column faster and more efficient, reduce the damage to mitochondrial membrane, and have good applicability, the present invention hereby provides a rat liver tissue mitochondrial membrane chromatography column and its preparation method and application.

[0031] The present invention provides a method for preparing a rat liver tissue mitochondrial membrane chromatography column, such as Figure 1 As shown, the method comprises the following steps:

[0032] Mitochondria were obtained by extracting rat liver tissue using differential centrifugation.

[0033] The mitochondria are ultrasonically crushed and broken in an ice bath to obtain a mitochondrial membrane fragment homogenate.

[0034] The mitochondrial membrane fragment homogenate is mixed with silica gel in a reaction container, incubated and centrifuged to obtain a precipitate to obtain a mitochondrial membrane stationary phase.

[0035] The mitochondrial membrane is treated by wet column packing to obtain the rat liver tissue mitochondrial membrane chromatography column.

[0036] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0037] 1. Rat Liver Mitochondria Extraction

[0038] (1) Pre-cool surgical scissors, a Dounce manual homogenizer, an appropriate amount of mitochondrial isolation medium, and PBS solution on ice.

[0039] (2) Take out 1 g of rat liver tissue pre-packed in a centrifuge tube and thaw it in water.

[0040] (3) After the liver tissue is thawed, add 1 mL of pre-cooled PBS solution to the tube and chop it with surgical scissors in an ice bath. Centrifuge briefly, discard the supernatant, and repeat the above steps until the supernatant is clear.

[0041] (4) Take the tissue fragment pellet and resuspend it in 1 mL of pre-cooled mitochondrial isolation medium. Transfer it to a pre-cooled Dounce manual homogenizer and grind it up and down 40 times in an ice bath. Do not allow air bubbles to enter during the grinding process to avoid damaging the mitochondria.

[0042] (5) Transfer the homogenized sample into a new 1.5 mL centrifuge tube and centrifuge at 4°C, 1000 g for 10 min. Discard the precipitate and take the supernatant.

[0043] (6) Transfer the supernatant into a new 1.5 mL centrifuge tube and centrifuge at 14,000 g at 4°C for 10 min.

[0044] (7) Discard the supernatant, add 1 mL of mitochondrial isolation medium to resuspend the pellet, and centrifuge at 12,000 g for 10 min at 4°C.

[0045] (8) Discard the supernatant, add 1 mL of mitochondrial isolation medium to resuspend the pellet, and centrifuge at 10,000 g for 10 min at 4°C.

[0046] (9) The resulting precipitate is the mitochondria. (If storage is required, resuspend it in a small amount of mitochondrial isolation medium and freeze it in a -80°C refrigerator.)

[0047] It should be noted that different centrifuges have different speed units, which are usually expressed in two ways: centrifugal force (g), i.e., acceleration due to gravity; and revolutions per minute (rpm). G is sometimes also expressed as relative centrifugal force (rcf). The g value (rcf) depends on the speed of the centrifuge rpm and the effective centrifugal radius r (unit: cm), and can be converted using the following formula:

[0048] For example: when the speed is 3000rpm and the effective centrifugal radius is 10cm, the centrifugal force (g) = 10x 118x 10-7x30002 = 1006.2 (g)

[0049] 2. Preparation of Mitochondrial Membrane Fragments

[0050] (1) Take 1 g of liver tissue corresponding to the mitochondrial precipitate, add 1 mL of hypotonic buffer to suspend the precipitate, and use an ultrasonic cell disruptor in an ice bath to disrupt the membrane (power 130 W, frequency 20 kHz, amplitude 40%, 2 s / time, interval 20 s, 5 cycles) to obtain mitochondrial membrane fragment homogenate.

[0051] (2) Place the homogenate in a centrifuge at 4°C, 1000 g, for 10 min, and take the supernatant homogenate.

[0052] (3) Take the precipitate from the previous step, add 1 mL of hypotonic buffer, and repeat the ultrasonic operation in step (1) to obtain a mitochondrial membrane fragment homogenate.

[0053] (4) Combine the homogenates from (2) and (3), centrifuge (12000 g, 20 min, 4°C), take the precipitate, add 1 mL of PBS and resuspend to obtain the mitochondrial membrane solution.

[0054] Western blot analysis was performed on the relative contents of related proteins in liver tissue homogenate, mitochondria, and mitochondrial membrane samples. All samples were adjusted to the same concentration and loaded with the same amount after BCA protein quantification. Figure 2 As shown. Figure 2 In the figure, (a) shows the expression levels of related proteins in the mitochondrial outer membrane, inner mitochondrial membrane, mitochondrial matrix and cytoplasmic matrix; (b) shows the statistical analysis of related proteins. *: p≤0.05; **: p≤0.01; ***: p≤0.001; ****: p≤0.0001. As can be seen from the figure, the mitochondrial outer membrane proteins VDAC and TOM20 are enriched in the extracted mitochondrial samples, and the enrichment degree is further improved in the mitochondrial membrane samples. Similarly, the mitochondrial inner membrane proteins COXⅣ and TIM23 are also similarly enriched in the mitochondrial samples and mitochondrial membrane samples, respectively. This shows that the mitochondrial preparation process has completed the separation of mitochondria very well, and the inner and outer membranes of mitochondria are broken and further enriched and purified during the membrane preparation process. This can also be reflected in the fact that CS protein and CytC protein in the mitochondrial matrix are enriched in mitochondrial samples but reduced in membrane samples. In addition, the relative amount of related proteins (β-actin) in the cytoplasmic matrix is ​​significantly reduced, indicating that most of the structures in the cytoplasmic matrix are separated, and then the mitochondria have a certain purity. In summary, the mitochondria were well separated, the mitochondria were successfully broken, and the mitochondrial membrane was successfully prepared.

[0055] The morphological structure of mitochondria after extraction and mitochondrial membrane after fragmentation can be observed by TEM, such as Figure 3 As shown. Figure 3In the figure, (a), (b), (c) and (d) are photos of mitochondrial samples at 4000, 10000, 30000 and 50000 magnifications respectively; (e), (f), (g) and (h) are photos of mitochondrial membrane samples at 4000, 10000, 30000 and 50000 magnifications respectively. Figure 3 As can be seen in (a), (b), (c) and (d), the mitochondria have been separated relatively completely, maintaining their relatively complete bilateral membrane structure. Their lengths are mostly concentrated between 500nm and 2μm, which is consistent with the length range of normal mitochondria, indicating that the process of extracting mitochondria can maintain the basic morphology and integrity of mitochondria. Figure 3 As can be seen in (e), (f), (g) and (h), most of the structures in the field of view are vesicles composed of a single membrane. The diameters of most vesicles are basically below 500 nm, and their areas are also smaller than mitochondria, indicating that the mitochondrial structure has been successfully broken and the mitochondrial membrane has been successfully prepared.

[0056] 3. Preparation process of mitochondrial membrane stationary phase (MMSP)

[0057] (1) Weigh 0.05 g of silica gel, place it in a test tube, put it in an oven, and activate it at 105°C for 30 min.

[0058] (2) Take out the activated silica gel, seal it with a rubber stopper after cooling, and connect the branch pipe of the supported test tube to the filtration device.

[0059] (3) Use a 5 mL medical syringe to extract the mitochondrial membrane solution prepared in Section 2.3.2. Turn on the filtration device and inject the liquid in the medical syringe into the supported test tube. Then place the supported test tube on a vortex machine under vacuum and vibrate for 2 min.

[0060] (4) Transfer the liquid in the test tube to a 10 mL centrifuge tube, add a magnetic stirrer and place in an ice bath for 30 min.

[0061] (5) After removing the magnet, place it in a 4°C refrigerator overnight.

[0062] (6) After overnight, centrifuge at 1000g, 4°C for 5 min and discard the supernatant. Wash the precipitate with PBS solution and centrifuge at 1000g. Repeat this three times. The final precipitate is the mitochondrial membrane stationary phase.

[0063] The surface morphology of silica gel and MMSP was characterized by SEM. Figure 4 As shown. Figure 4In the figure, (a) is silica gel, 10,000 times magnified; (b) is MMSP, 10,000 times magnified; (c) is silica gel, 2,000 times magnified; (d) is MMSP, 2,000 times magnified. Figure 4 As can be seen in (a) and (c), the untreated silica gel surface is smooth and evenly dispersed in the detection background. Figure 4 As can be seen in (b) and (d), the surface of MMSP is relatively rough and covered with a layer of film-like substance, which preliminarily proves that the preparation of MMSP is successful.

[0064] After silica gel is adsorbed on the mitochondrial membrane, its surface elements will change. XPS is used to analyze the surface elements of silica gel and MMSP. The results are as follows: Figure 5 As shown. Figure 5 In the figure, (a) is the full XPS scan spectrum of the two stationary phases, from which the changes in the content of each element can be intuitively seen. (b) and (c) are detailed spectrum scans of N1s and P2p. It can be seen that compared with the untreated silica gel, MMSP has characteristic peaks of nitrogen and phosphorus, indicating that the mitochondrial membrane is adsorbed on the surface of the silica gel, further demonstrating that the preparation of MMSP is successful.

[0065] Since mitochondrial membrane proteins exist on the surface of MMSP, they can be characterized by staining with corresponding fluorescent antibodies, and the phospholipid membrane structure can be characterized by Dil staining. The results are shown in Figure 6 As shown. Figure 6 In the figure, (a), (b), and (c) are immunofluorescence images of Tom20 antibody and co-staining with Dil stain; (d), (e), and (f) are immunofluorescence images of Tim23 antibody and co-staining with Dil stain; more specifically, (a) is immunofluorescence staining of Tom20 antibody; (b) is staining with Dil stain; (c) is co-localization of a and b; (d) is immunofluorescence staining of Tim23 antibody; (e) is staining with Dil stain; (f) is co-localization image of d and e. Figure 6 As can be seen in (b) and (d), the red fluorescence on the surface of MMSP indicates that the membrane structure is adsorbed on the silica gel; as can be seen in (a) and (e), the green fluorescence indicates that its surface contains the mitochondrial outer membrane-specific Tom20 protein and the mitochondrial and mitochondrial inner membrane-specific protein Tim23; as can be seen in (c) and (f), the co-localization results indicate that the location of the membrane structure is highly consistent with the location of the mitochondrial inner and outer membrane-specific proteins. This further indicates that there is a membrane structure on the surface of MMSP and that the membrane structure contains both the mitochondrial outer and inner membranes. In summary, it can be shown that MMSP was successfully prepared.

[0066] 4. Preparation of Mitochondrial Membrane Chromatography Column

[0067] Take the core of the chromatographic column (10mm×2mm ID), install a sieve plate on one end and an empty sieve plate on the other end, and put the empty sieve plate into the column sleeve of the column packing machine with the end facing upwards. Open the nut on the upper end of the homogenization tube of the column packing machine, mix the prepared mitochondrial membrane stationary phase suspension and inject it into the homogenization tube of the column packing machine, turn on the column packing machine, pack the column at a flow rate of 1mL / min for 20min, turn off the column packing machine, take out the column core and remove the empty sieve plate, replace it with a common sieve plate, and the cell membrane chromatography column can be obtained. Put the chromatographic column into a special column sleeve and connect it to the HPLC instrument to form a mitochondrial membrane chromatography system. It can also be placed in a test tube containing an appropriate amount of physiological saline (to submerge the chromatographic column) and stored at 4℃ for later use.

[0068] 5. Applicability of Mitochondria Membrane Chromatography (MMC) System

[0069] 5.04 mg of dipyridamole and 4.94 mg of glibenclamide were accurately weighed and placed in 15 mL centrifuge tubes, 8 mL of chromatographic grade methanol was added to each and shaken to dissolve, and then chromatographic grade methanol was added to 10 mL to obtain 1 mmol / L reference stock solutions, which were diluted to 100 μmol / L and placed in liquid chromatography injection bottles for subsequent injection, with the injection volume set to 10 μL. The selectivity, specificity, repeatability and column life of the MMC system were investigated using disodium hydrogen phosphate with a concentration of 2 mmol / L and a pH of 7.4 as the mobile phase, with a flow rate set to 0.2 mL / min and a column temperature of 37 °C.

[0070] The retention behaviors of positive drugs dipyridamole and glibenclamide on silica gel column, Hela / CMC column and MMC column were used to investigate the specificity of the MMC column. Figure 7 As shown. Figure 7 In the figure, (a) is a silica gel column for dipyridamole injection; (b) is a Hela / CMC column for dipyridamole injection; (c) is an MMC column for dipyridamole injection; (d) is a silica gel column for glibenclamide injection; (e) is a Hela / CMC column for glibenclamide injection; (f) is an MMC column for glibenclamide injection. Figure 7 As can be seen from (a), (b), (d), and (e), dipyridamole and glibenclamide are not retained on the silica gel column and Hela / CMC column; as can be seen from (c) and (f), the retention times on the MMC column are 1.935 min and 2.121 min, respectively. This result shows that mitochondrial positive drugs can be specifically identified on the MMC column and cannot be identified by the silica gel column and non-mitochondrial membrane column, which further shows that the MMC column has specificity.

[0071] The selectivity of the MMC column was investigated by measuring the retention behaviors of the positive drugs dipyridamole and glibenclamide and the negative drugs capulotin and methanol solvent on the MMC column. Figure 8 Shown in Figure 8 In the figure, (a) is dipyridamole; (b) is glibenclamide; (c) is methanol injection; (d) is captopril. Figure 8 As can be seen from (a) and (b), dipyridamole and glibenclamide are clearly retained on the MMC column; as can be seen from (c) and (d), methanol solvent and negative drug capulotil are not retained on the column. The results show that the MMC column has good selectivity and can specifically identify drugs that act on the mitochondrial membrane.

[0072] Taking glibenclamide as an example, the retention time (tR) was used to evaluate the intra-column and inter-column repeatability of the MMC column, and the results are listed in the table below. The glibenclamide reference solution was injected 5 times on the same MMC column to examine its intra-column repeatability. The relative standard deviation (RSD) of the 5 retention times was equal to 3.2% (n=5), and its RSD value was less than 5%, indicating that the chromatographic column had excellent intra-column repeatability. The glibenclamide reference solution was injected on 3 MMC columns prepared by the same method, and the RSD value of its retention time was 24.1% (n=3), indicating that it had a certain inter-column repeatability, but the repeatability was slightly poor.

[0073] Table 1 Results of MMC column repeatability test

[0074]

[0075]

[0076] The MMC column separates the mixture based on the affinity of the membrane receptor to the ligand, so the duration of receptor activity means the life of the MMC column, which can be measured by the retention time (t R ) to detect the column life. The results are as follows Fig. 9 As shown, with methanol as the non-retained component and its retention time as the control, glibenclamide can be separated and identified on the chromatographic column for three consecutive days, and its retention time is close to that of the non-retained components after the fourth day, indicating that the life of the MMC column is about 3 days.

[0077] It can be seen that the chromatographic column has good applicability after investigation and can be used to screen mitochondrial drugs and study the interaction between mitochondrial drugs and mitochondria, and can be used as a new tool for studying mitochondrial biomedicine.

[0078] Those skilled in the art can understand that the above-mentioned embodiments are specific examples for implementing the present application, and in practical applications, various changes can be made to them in form and detail without departing from the spirit and scope of the present application. Any person skilled in the art can make their own changes and modifications without departing from the spirit and scope of the present application, so the scope of protection of the present application shall be based on the scope defined in the claims.

Claims

1. A method for preparing a rat liver tissue mitochondrial membrane chromatography column, characterized in that: The method comprises the following steps: Differential centrifugation was used to extract mitochondria from rat liver tissue; The mitochondria are ultrasonically crushed and broken into membranes in an ice bath to obtain a mitochondrial membrane fragment homogenate; The mitochondrial membrane fragment homogenate is mixed with silica gel in a reaction container, and after incubation, the mixture is centrifuged to obtain a precipitate to obtain a mitochondrial membrane stationary phase; The mitochondrial membrane is treated by wet column packing to obtain the rat liver tissue mitochondrial membrane chromatography column.

2. The method for preparing the rat liver tissue mitochondrial membrane chromatography column according to claim 1, characterized in that: The ultrasonic crushing and membrane breaking specifically includes the following parameters: power 130W, frequency 20kHz, amplitude 40%, 2s / time, interval 20s, 5 cycles.

3. The method for preparing the rat liver tissue mitochondrial membrane chromatography column according to claim 1, characterized in that: The silica gel is spherical granular silica gel, the diameter of a single silica gel particle is 5 μm, and the diameter of the pore size is 10 nm.

4. The method for preparing the rat liver tissue mitochondrial membrane chromatography column according to claim 1, characterized in that: The incubation time is 12 hours; the specific parameters of the centrifugation are: 12000g, centrifugation for 20 minutes.

5. The method for preparing the rat liver tissue mitochondrial membrane chromatography column according to claim 1, characterized in that: The method also includes: using positive drugs and negative drugs to respectively examine the specificity, selectivity, repeatability and column life applicability parameters of the rat liver tissue mitochondrial membrane chromatography column.

6. A rat liver tissue mitochondrial membrane chromatography column prepared by the preparation method of the rat liver tissue mitochondrial membrane chromatography column as described in any one of claims 1 to 5.

7. Application of the rat liver tissue mitochondrial membrane chromatography column as claimed in claim 6 in the field of screening mitochondrial effector molecules and studying the interaction between mitochondrial membrane and effector molecules.